Aripiprazole in the treatment of olanzapine-resistant psychotic and motor symptoms of Huntington's disease.
Oulis
Panagiotis
P
Mourikis
Iraklis
I
Konstantakopoulos
George
G
Papageorgiou
Sokratis G
SG
Kouzoupis
Anastasios V
AV
D014150:Antipsychotic Agents / Q000627:therapeutic use; D000068180:Aripiprazole; D001569:Benzodiazepines / Q000627:therapeutic use*; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000077152:Olanzapine; D010879:Piperazines / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy*; D015363:Quinolones / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D001569:Benzodiazepines; D000068180:Aripiprazole; D000077152:Olanzapine